BioStem Technologies, Inc.BioStem Technologies, Inc.BioStem Technologies, Inc.

BioStem Technologies, Inc.

No trades
See on Supercharts
Market capitalization
‪162.27 M‬USD
−0.44USD
‪−7.86 M‬USD
‪16.69 M‬USD
Beta (1Y)
1.58

About BioStem Technologies, Inc.

CEO
Jason Matuszewski
Headquarters
Pompano Beach
Founded
1939
ISIN
US0906842002
FIGI
BBG000JZMW15
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BSEM is 9.80 USD — it has decreased by 2.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BioStem Technologies, Inc. stocks are traded under the ticker BSEM.
BioStem Technologies, Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
BSEM stock is 5.13% volatile and has beta coefficient of 1.58. Check out the list of the most volatile stocks — is BioStem Technologies, Inc. there?
One year price forecast for BioStem Technologies, Inc. has a max estimate of 22.25 USD and a min estimate of 22.25 USD.
BSEM earnings for the last quarter are 0.03 USD whereas the estimation was −0.18 USD which accounts for 116.67% surprise. Estimated earnings for the next quarter are 0.16 USD. See more details about BioStem Technologies, Inc. earnings.
BioStem Technologies, Inc. revenue for the last quarter amounts to ‪3.60 M‬ USD despite the estimated figure of ‪1.39 M‬ USD. In the next quarter revenue is expected to reach ‪11.40 M‬ USD.
Yes, you can track BioStem Technologies, Inc. financials in yearly and quarterly reports right on TradingView.
BSEM stock has fallen by 31.99% compared to the previous week, the month change is a 3.59% rise, over the last year BioStem Technologies, Inc. has showed a 390.00% increase.
BSEM net income for the last quarter is ‪−2.12 M‬ USD, while the quarter before that showed ‪367.32 K‬ USD of net income which accounts for −677.52% change. Track more BioStem Technologies, Inc. financial stats to get the full picture.
Today BioStem Technologies, Inc. has the market capitalization of ‪134.70 M‬, it has increased by 8.39% over the last week.
No, BSEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BSEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioStem Technologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BSEM reached its all-time high on May 27, 2009 with the price of 14700.42 USD, and its all-time low was 0.01 USD and was reached on Dec 3, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioStem Technologies, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioStem Technologies, Inc. stock shows the buy signal. See more of BioStem Technologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BioStem Technologies, Inc. future price: according to them, BSEM price has a max estimate of 22.25 USD and a min estimate of 22.25 USD. Read a more detailed BioStem Technologies, Inc. forecast: see what analysts think of BioStem Technologies, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioStem Technologies, Inc. EBITDA is ‪−5.18 M‬ USD, and current EBITDA margin is −41.53%. See more stats in BioStem Technologies, Inc. financial statements.